Literature DB >> 8579785

Structure of a tumor associated antigen containing a tandemly repeated immunodominant epitope.

J D Fontenot1, S V Mariappan, P Catasti, N Domenech, O J Finn, G Gupta.   

Abstract

Human mucins are T or S glycosylated tandem repeat proteins. In breast cancer, mucins become under or unglycosylated. Two-dimensional nuclear magnetic resonance experiments are performed on chemically synthesized mucin tandem repeat polypeptides, (PDTRPAPGST-APPAHGVTSA)n the unglycosylated form for n=1,3 where (APDTR) constitutes the antigenic sites for the antibodies isolated form the tumors in the breast cancer patients. These studies demonstrate how the tandem repeats assemble in space giving rise to the overall tertiary structure, and the local structure and presentation of the antigenic site(APDTR) at the junction of two neighboring repeats. The NMR data reveal repeating knob-like structures connected by extended spacers. The knobs protrude away from the long-axis of Muc-1 and the predominant antigenic site (APDTR) forms the accessible tip of the knob. Multiple tandem repeats enhance the rigidity and presentation of the knob-like structures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8579785     DOI: 10.1080/07391102.1995.10508837

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  16 in total

Review 1.  MUC1-mediated motility in breast cancer: a review highlighting the role of the MUC1/ICAM-1/Src signaling triad.

Authors:  Lacey Haddon; Judith Hugh
Journal:  Clin Exp Metastasis       Date:  2015-03-11       Impact factor: 5.150

2.  NEU1 Sialidase Regulates Membrane-tethered Mucin (MUC1) Ectodomain Adhesiveness for Pseudomonas aeruginosa and Decoy Receptor Release.

Authors:  Erik P Lillehoj; Sang Won Hyun; Anguo Liu; Wei Guang; Avelino C Verceles; Irina G Luzina; Sergei P Atamas; K Chul Kim; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2015-05-11       Impact factor: 5.157

3.  Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state.

Authors:  Y Altschuler; C L Kinlough; P A Poland; J B Bruns; G Apodaca; O A Weisz; R P Hughey
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

4.  A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies.

Authors:  Kathryn L Terry; Allison F Vitonis; Dena Hernandez; Galina Lurie; Honglin Song; Susan J Ramus; Linda Titus-Ernstoff; Michael E Carney; Lynne R Wilkens; Aleksandra Gentry-Maharaj; Usha Menon; Simon A Gayther; Paul D Pharaoh; Marc T Goodman; Daniel W Cramer; Michael J Birrer
Journal:  Int J Mol Epidemiol Genet       Date:  2010-07-26

5.  Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution.

Authors:  Nehad M Alajez; Jan Schmielau; Mark D Alter; Michael Cascio; Olivera J Finn
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

6.  Topological mimicry and epitope duplication in the guanylyl cyclase C receptor.

Authors:  A Nandi; K Suguna; A Surolia; S S Visweswariah
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

7.  Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells.

Authors:  G Pecher; O J Finn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

8.  Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles.

Authors:  Xuanjun Wu; Craig McKay; Christian Pett; Jin Yu; Manuel Schorlemer; Sherif Ramadan; Shuyao Lang; Sandra Behren; Ulrika Westerlind; M G Finn; Xuefei Huang
Journal:  ACS Chem Biol       Date:  2019-09-19       Impact factor: 5.100

9.  Proline-rich tandem repeats of antibody complementarity-determining regions bind and neutralize human immunodeficiency virus type 1 particles.

Authors:  J D Fontenot; V R Zacharopoulos; D M Phillips
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.

Authors:  Sang W Hyun; Anguo Liu; Zhenguo Liu; Alan S Cross; Avelino C Verceles; Sadagopan Magesh; Yadagiri Kommagalla; Chandrababunaidu Kona; Hiromune Ando; Irina G Luzina; Sergei P Atamas; Kurt H Piepenbrink; Eric J Sundberg; Wei Guang; Hideharu Ishida; Erik P Lillehoj; Simeon E Goldblum
Journal:  Glycobiology       Date:  2016-05-25       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.